1-8 of 8
Yue Dang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline osmr mutation drives familial unicentric castleman disease with osteosclerosis

Free
Miaoyan Zhang, Yan-ting Liu, Yue Dang, Yu-han Gao, Siyuan Li, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 3536.
https://doi.org/10.1182/blood-2025-3536
Published: 2025
Journal Articles

Prognostic significance of pulmonary involvement in idiopathic multicentric castleman disease

Free
Yu-han Gao, Jia-min Zhou, Cong-Wei Jia, Siyuan Li, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1229.
https://doi.org/10.1182/blood-2025-1229
Published: 2025
Journal Articles

Is 'severe’ imcd-IPL really severe?

Free
Siyuan Li, Yu-han Gao, Yue Dang, Jian Li, Lu Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1816.
https://doi.org/10.1182/blood-2025-1816
Published: 2025
Journal Articles

PRKRA associated with NF-κB activation in pulmonary involvement of idiopathic multicentric castleman disease

Free
Yu-han Gao, Cong-Wei Jia, Zhi-yuan Li, Jia-min Zhou, Zhen-huan Tian, Siyuan Li, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 4784.
https://doi.org/10.1182/blood-2025-4784
Published: 2025
Journal Articles

Potential Opportunity for Drug Discontinuation in Idiopathic Multicentric Castleman Disease: Evaluating the Efficacy of TCP Protocol

Free
Yue Dang, Yuhan Gao, Siyuan Li, Lu Zhang, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6310.
https://doi.org/10.1182/blood-2024-206712
Published: 2024
Journal Articles

Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Idiopathic Multicentric Castleman Disease: A Single-Center, Retrospective Study

Free
Yuhan Gao, Siyuan Li, Yue Dang, Minghui Duan, Jian Li, Lu Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1656.
https://doi.org/10.1182/blood-2024-204570
Published: 2024
Journal Articles

Tafro Syndrome without Pathological Evidence Consistent with Castleman Disease: A Subtype of Tafro or a Distinct Disease Entity?

Free
Siyuan Li, Yuhan Gao, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6298.
https://doi.org/10.1182/blood-2024-204501
Published: 2024
Journal Articles

Real-World Data of Siltuximab for Chinese Patients with Imcd: Combination with BCD Regimen Benefits Severe Cases

Free
Siyuan Li, Yuhan Gao, Yue Dang, Long Chang, Kaini Shen, Huacong Cai, Danqing Zhao, Chong Wei, Jun Feng, Lu Zhang, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6292.
https://doi.org/10.1182/blood-2024-203586
Published: 2024